The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients

被引:0
|
作者
Bonigliere, L. [1 ]
Torrisi, R. [1 ]
Pruneri, G. [1 ]
Colleoni, M. [1 ]
Viale, G. [1 ]
机构
[1] European Inst Oncol, Milan, Italy
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
97
引用
收藏
页码:24A / 24A
页数:1
相关论文
共 50 条
  • [31] Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy
    Colleoni, M.
    Viale, G.
    Zahrieh, D.
    Bottiglieri, L.
    Gelber, R. D.
    Veronesi, P.
    Balduzzi, A.
    Torrisi, R.
    Luini, A.
    Intra, M.
    Dellapasqua, S.
    Cardillo, A.
    Ghisini, R.
    Peruzzotti, G.
    Goldhirsch, A.
    ANNALS OF ONCOLOGY, 2008, 19 (03) : 465 - 472
  • [32] Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
    Andrea Sassen
    Justine Rochon
    Peter Wild
    Arndt Hartmann
    Ferdinand Hofstaedter
    Stephan Schwarz
    Gero Brockhoff
    Breast Cancer Research, 10
  • [33] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    Luciana de Moura Leite
    Marcelle Goldner Cesca
    Monique Celeste Tavares
    Debora Maciel Santana
    Erick Figueiredo Saldanha
    Paula Tavares Guimarães
    Daniella Dias Silva Sá
    Maria Fernanda Evangelista Simões
    Rafael Lima Viana
    Francisca Giselle Rocha
    Simone Klog Loose
    Sinara Figueiredo Silva
    Rafaela Pirolli
    Camilla Albina Zanco Fogassa
    Bruna Raphaeli Silva Mattos
    Fernando Augusto Batista Campos
    Solange Moraes Sanches
    Vladmir Cláudio Cordeiro de Lima
    Noam Falbel Pondé
    Breast Cancer Research and Treatment, 2021, 190 : 155 - 163
  • [34] Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
    Sassen, Andrea
    Rochon, Justine
    Wild, Peter
    Hartmann, Arndt
    Hofstaedter, Ferdinand
    Schwarz, Stephan
    Brockhoff, Gero
    BREAST CANCER RESEARCH, 2008, 10 (01):
  • [35] Analysis of HER1 and HER2 status in CNS metastases from patients (pts) with breast carcinoma (BC)
    Viale, G.
    Del Curto, B.
    Orvieto, E.
    Maiorano, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] HER2-low status and response to neoadjuvant chemotherapy in HER2 negative early breast cancer
    de Moura Leite, Luciana
    Cesca, Marcelle Goldner
    Tavares, Monique Celeste
    Santana, Debora Maciel
    Saldanha, Erick Figueiredo
    Guimaraes, Paula Tavares
    Sa, Daniella Dias Silva
    Simoes, Maria Fernanda Evangelista
    Viana, Rafael Lima
    Rocha, Francisca Giselle
    Loose, Simone Klog
    Silva, Sinara Figueiredo
    Pirolli, Rafaela
    Fogassa, Camilla Albina Zanco
    Mattos, Bruna Raphaeli Silva
    Campos, Fernando Augusto Batista
    Sanches, Solange Moraes
    de Lima, Vladmir Claudio Cordeiro
    Ponde, Noam Falbel
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (01) : 155 - 163
  • [37] Salivary expression of soluble HER2 in breast cancer patients with positive and negative HER2 status
    Laidi, Fatna
    Bouziane, Amal
    Lakhdar, Amina
    Khabouze, Samira
    Rhrab, Brahim
    Zaoui, Fatima
    ONCOTARGETS AND THERAPY, 2014, 7 : 1285 - 1289
  • [38] Decreased HER2 expression in residual disease following neoadjuvant therapy in patients with HER2-positive breast cancer
    Mogica, Jan Paredes
    Tang, Haiming
    Fischbach, Neal A.
    Zhan, Haiying
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Predictive Biomarker of Response to Neoadjuvant Therapy in HER2 Positive Breast Cancer
    Zhao, Jing
    Meisel, Jane
    Suo, Aili
    Zhang, Chao
    Wei, Zhimin
    Aneja, Ritu
    Li, Zaibo
    Nahta, Rita
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [40] Stability of HER2 Expression in Residual Breast Cancer Following Neoadjuvant Anti-HER2 Therapy
    Mir, Mariam O.
    Sahoo, Sunati
    Fang, Yisheng
    Peng, Yan
    Hwang, Helena
    Czapla, Agata
    Koduru, Prasad
    Sarode, Venetia
    LABORATORY INVESTIGATION, 2018, 98 : 91 - 91